Clinical trial
XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-Arm Study
NCT00631228 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-Arm Study
- Lead sponsor
- Abbott Medical Devices
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- August 31, 2012
- Enrollment
- 1,000 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.